PFMU
CABA icon

Privium Fund Management (UK)’s Cabaletta Bio CABA Stock Holding History

Privium Fund Management (UK)’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-331,218
Closed -$215K – 56
2022
Q3 		$215K Buy
+331,218
New +$399K 0.27% 45

Other funds holding CABA

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Privium Fund Management (UK)'s CABA Position: Q4 2022 in Review

Privium Fund Management (UK) sold out of Cabaletta Bio (CABA) in Q4 2022, closing a stake of 331,218 shares — an estimated $215K sold.

Privium Fund Management (UK) first reported a position in CABA in Q3 2022 and held it in 1 quarter. The position peaked at $215K in Q3 2022. 61 funds tracked by Wall St. Rank hold CABA as of Q4 2022.

  • Privium Fund Management (UK) reported no remaining Cabaletta Bio position as of Q4 2022 after selling out during the quarter.
  • Privium Fund Management (UK) sold 331,218 Cabaletta Bio shares in Q4 2022, an estimated $215K.
  • Privium Fund Management (UK) first reported a position in Cabaletta Bio in Q3 2022 and held it in 1 quarter.
  • Privium Fund Management (UK)'s Cabaletta Bio position peaked at $215K in Q3 2022.
  • 61 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2022.

Based on Privium Fund Management (UK)'s 13F filing for Q4 2022, filed 9 Feb 2023.